Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.51 USD | 0.00% | +2.99% | +21.86% |
29/04 | Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER | CI |
11/04 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Bullish |
Resistance | 37.96 | 40.91 | 39.99 |
Spread/Res. | -1.19% | -8.31% | -6.20% |
Spread/Supp. | +7.97% | +25.75% | +30.56% |
Support | 34.74 | 29.83 | 28.73 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- COLL Stock
- Charts Collegium Pharmaceutical, Inc.